accountInc. (POZN); blood thinner Brilinta, previously known as AZD6140, and a combination pill containing cholesterol drugs Crestor and Abbott Laboratories' (ABT) TriLipix. AstraZeneca's key experimental drug, diabetes treatment Onglyza, is under regulatory...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to 3rd UPDATE: AstraZeneca Posts Lower 4Q Pfts, Unveils Job Cuts
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account